DANIEL RUBALCAVA

Concepts (70)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Spinal Injuries
4
2025
35
0.870
Why?
Wounds, Nonpenetrating
5
2025
218
0.870
Why?
Cervical Vertebrae
4
2025
102
0.840
Why?
Phenytoin
2
2020
54
0.460
Why?
Valproic Acid
2
2020
140
0.440
Why?
Status Epilepticus
2
2020
159
0.400
Why?
Emergency Service, Hospital
6
2025
1224
0.390
Why?
Anticonvulsants
2
2020
363
0.380
Why?
Wounds, Gunshot
2
2024
148
0.320
Why?
Physical Abuse
2
2023
24
0.320
Why?
Emergency Medical Services
1
2025
352
0.170
Why?
Simulation Training
1
2024
153
0.170
Why?
Surgeons
1
2025
289
0.160
Why?
Child Abuse
1
2023
228
0.150
Why?
Infant
9
2025
13352
0.140
Why?
Prospective Studies
6
2025
6459
0.140
Why?
Child
12
2025
26341
0.130
Why?
Child, Preschool
8
2025
15110
0.130
Why?
Torso
1
2017
13
0.130
Why?
Near Drowning
1
2017
29
0.130
Why?
Pelvic Bones
1
2017
25
0.130
Why?
Accidents, Traffic
1
2017
102
0.120
Why?
Adolescent
9
2025
20987
0.120
Why?
Accidental Falls
1
2017
112
0.120
Why?
Fractures, Bone
1
2017
214
0.110
Why?
Antivenins
1
2014
13
0.100
Why?
Snake Bites
1
2014
17
0.100
Why?
Double-Blind Method
2
2020
1626
0.090
Why?
Male
11
2025
64957
0.080
Why?
Female
11
2025
70963
0.080
Why?
Disease Management
1
2014
558
0.080
Why?
Predictive Value of Tests
2
2025
2304
0.080
Why?
Injections, Intramuscular
1
2019
185
0.070
Why?
Drug Resistance
1
2019
242
0.070
Why?
Benzodiazepines
1
2019
107
0.070
Why?
Infusions, Intravenous
1
2019
531
0.070
Why?
Hypotension
1
2019
187
0.070
Why?
Sensitivity and Specificity
2
2025
2085
0.060
Why?
Humans
12
2025
131163
0.060
Why?
Infant, Newborn
3
2025
8635
0.060
Why?
Observer Variation
1
2025
311
0.050
Why?
Physical Examination
1
2025
171
0.050
Why?
Anti-Bacterial Agents
1
2014
2596
0.040
Why?
Resuscitation
1
2024
258
0.040
Why?
Educational Measurement
1
2024
320
0.040
Why?
Young Adult
2
2020
10103
0.040
Why?
Learning
1
2024
356
0.040
Why?
Retrospective Studies
4
2023
17753
0.040
Why?
Recreation
1
2020
18
0.040
Why?
Age Distribution
1
2020
422
0.040
Why?
Reproducibility of Results
1
2025
2904
0.030
Why?
Hospitalization
2
2017
1950
0.030
Why?
Algorithms
1
2024
1680
0.030
Why?
Texas
2
2017
3686
0.030
Why?
Patient Outcome Assessment
1
2017
89
0.030
Why?
Injury Severity Score
1
2017
235
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1618
0.030
Why?
Tomography, X-Ray Computed
1
2024
2065
0.030
Why?
Middle Aged
2
2020
28601
0.030
Why?
Adult
2
2020
31282
0.030
Why?
Age Factors
1
2020
2825
0.020
Why?
Logistic Models
1
2017
1797
0.020
Why?
Aged, 80 and over
1
2020
6797
0.020
Why?
Cross-Sectional Studies
1
2017
3829
0.020
Why?
Risk Assessment
1
2017
3711
0.020
Why?
Length of Stay
1
2014
1421
0.020
Why?
Incidence
1
2014
3360
0.010
Why?
Follow-Up Studies
1
2014
5196
0.010
Why?
Risk Factors
1
2017
11074
0.010
Why?
Aged
1
2020
21025
0.010
Why?
RUBALCAVA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_